Sales & Marketing HSA growth and the opportunities emerging for investors and ... Paying attention to the intersection of public policy and business opportunity can be a winning strategy for start-ups and disrupters.
Partner Content Partner Content IATA's CEIV-Pharma Certification or HSA's GDP Certification? 13th Cold Chain Distribution Conference
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.